Are the New Sleep Medications Safer Than the Old Ones? DORAs vs Z-Drugs and Benzodiazepines

Are the New Sleep Medications Safer Than the Old Ones? DORAs vs Z-Drugs and Benzodiazepines

Most people who ask us about sleeping pills are not really asking whether they work. They are asking whether they are safe. Will I get hooked? Will I feel like a zombie in the morning? Will I need a higher and higher dose to get the same effect? Those worries are well earned, because for a long time the most common prescription sleep medications came with exactly those trade-offs.

A newer class of medication, the dual orexin receptor antagonists or DORAs, was designed around those concerns. Here is how the older and newer options actually compare on the safety questions that matter most.

How older sleeping pills work

Most older prescription sleep medication works by sedating the brain. Benzodiazepines, the so-called Z-drugs like zopiclone, and off-label use of antihistamines all sit somewhere in that category. They can make you feel drowsy enough to fall asleep, which is why they are effective in the short term. The downside is in how they do it.

Because they sedate rather than release the brain into natural sleep, they often leave you groggy the next day. And many of them carry a real risk of dependence with long-term use, along with tolerance, where the same dose gradually does less over time. That combination is why guidelines have long recommended using these medications for the shortest time possible, and why so many people who have been on them for years feel stuck.

How DORAs work differently

DORAs take a different approach. Instead of pushing the brain toward sleep, they quiet the wake signal. Orexin is a brain chemical that helps keep you alert during the day. A dual orexin receptor antagonist temporarily blocks the orexin receptors at night so that natural sleep can happen on its own.

That distinction, wake blocker versus sedative, is the whole point. Because DORAs are not sedatives, they are not designed to knock you out, and they are generally not associated with the next-day grogginess that older sedating sleep medications can cause. The two DORAs Canadian sleep clinics now discuss are QUVIVIQ (daridorexant) and Dayvigo (lemborexant).

The dependence question

This is the one most people care about, so it is worth being precise. In the published literature, patients who stopped DORAs abruptly, even after about a year of continuous use, did not experience rebound insomnia or withdrawal. On that basis, DORAs are not thought to cause dependence or tolerance and are not considered habit forming.

That is a meaningful difference from the older sedating options, and it is part of why recent Canadian and European insomnia guidelines list the DORA class as a first-line medication option for chronic insomnia. It does not mean DORAs are risk free or that you should start or stop them on your own. Any prescription sleep medication should be used under medical guidance.

The next-day grogginess question

Feeling foggy, slow, or unsafe behind the wheel the morning after is one of the most common reasons people abandon a sleep medication. Because older options sedate the brain, that hangover effect is a familiar problem. DORAs, acting as wake blockers rather than sedatives, are generally not associated with that same next-day grogginess.

That said, individual response varies. If you drive, operate heavy equipment, or have a job that demands quick reaction times in the morning, your prescriber will want to talk about timing and dose, and alcohol and other central nervous system depressants should generally be avoided with either DORA.

DORAs are not a free pass

Newer and better tolerated does not mean without side effects. The most commonly reported side effects for both DORAs include headache, daytime drowsiness or somnolence, and unusual or vivid dreams. Less commonly, some patients have reported sleep paralysis or brief muscle weakness when waking. These risks are exactly why these medications require a prescription and a careful conversation about your full medical history.

There is also the question of whether medication is the right tool at all. For many people with chronic insomnia, cognitive behavioural therapy for insomnia (CBT-I) is the most durable first step, and it treats the root pattern rather than the symptom. Sometimes the reason sleep is broken is not insomnia at all but an underlying disorder such as sleep apnea, which no sleeping pill will fix. That is why the safest plan usually starts with understanding the cause.

So, are the new options safer?

On the two concerns that drive most of the worry, dependence and next-day grogginess, the evidence for DORAs is genuinely reassuring compared with the older sedating medications, which is why guidelines now place them as a first-line option. But safer is not the same as harmless, and the right choice still depends on your history, your other medications, and what is actually causing your sleep problem.

Frequently asked questions

Are DORAs like QUVIVIQ and Dayvigo addictive? Based on the published literature, no. Patients who stopped them abruptly, even after about a year of use, did not show rebound insomnia or withdrawal, so they are not thought to cause dependence or tolerance. They should still be used under medical guidance.

Is zopiclone addictive? Z-drugs like zopiclone and other older sedating sleep medications carry a real risk of dependence with long-term use, which is why they are generally recommended for short-term use. Talk to your prescriber about your specific situation.

Will a DORA make me groggy in the morning? DORAs act as wake blockers rather than sedatives, so they are generally not associated with the next-day grogginess older options can cause. Individual response varies, so timing and dose are worth discussing.

Should I switch from my current sleeping pill to a DORA? That is a conversation for your prescriber, especially if you have been on an older medication for a long time and want a safer long-term plan. Do not stop or switch on your own.

Is medication even the right first step? Not always. CBT-I is a durable first-line treatment for chronic insomnia, and some sleep problems are caused by disorders like sleep apnea that medication will not address. A proper assessment comes first.

Talk to a sleep specialist in Alberta

If you have been relying on an older sleep medication, or you are nervous about starting one at all, it is worth understanding your full range of options. If you are in Alberta, book a consultation with The Sleep Institute or start with a self-referral. We look at the whole picture, your sleep history, related sleep disorders, and your goals, and help you find the safest path to better sleep.

Back to blog